ABT vs BRFH · P/E 25, rev $44.33B vs rev $10.3M
Abbott Laboratories (ABT) versus Barfresh Food Group Inc (BRFH) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Barfresh Food Group Inc (BRFH) is a beverages - non-alcoholic company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported BRFH revenue for 2026-06-30 was $10.3M. Net income was -$2.5M. Revenue was up 83.6% from 2026-03-31 to 2026-06-30. BRFH currently screens at market cap $37.6M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. BRFH currently screens at market cap $37.6M.
Not investment advice. Open the ABT and BRFH stock pages for the full models.
Not investment advice.